P21 (also called P021) is a small synthetic peptide made from the most active part of ciliary neurotrophic factor (CNTF), a natural protein that helps nerve cells grow and survive. Scientists designed it to copy some of CNTF’s effects in the brain while being small and stable enough to study in animals. So far, every published study has been in cells, mice or rats, not people.
Searches for “P21 peptide” have grown as interest in brain and memory research has picked up. This guide from Peptides UK explains, in plain English, what P21 is, how researchers think it works, what the studies actually found and where the evidence stops. For laboratory research use only.
What is P21 peptide in simple terms?
Your nervous system relies on a family of proteins called neurotrophic factors. They help nerve cells survive, connect and, in a few brain areas, form new neurons. CNTF is one of them, and BDNF (brain-derived neurotrophic factor) is another.
The problem for researchers is that these proteins are large. They break down quickly and struggle to get from the bloodstream into the brain. So a team at the New York State Institute for Basic Research looked for the smallest active piece of CNTF and built a short peptide around it. That peptide was first reported in 2010 as P21 (Li et al., FEBS Letters, 2010). Later papers from the same group usually call it P021 or Peptide 021.
One quick point to avoid confusion: P21 the peptide is not the same as p21 (CDKN1A), a protein inside cells that helps control cell division. They simply share a similar name.
P21 peptide structure: what is it made of?
P21 is tiny compared with the protein it came from. Published papers describe it as Ac-DGGL(A)G-NH2. Broken down, that means:
- D-G-G-L: four amino acids (aspartic acid, glycine, glycine, leucine) taken from CNTF by a process called epitope mapping.
- (A)G: a glycine carrying an adamantane group. Adamantane is a bulky, cage-shaped molecule. The researchers added it to slow down breakdown by enzymes and to help the peptide reach the brain in animal studies (Baazaoui and Iqbal, 2017).
- Ac and NH2: caps on each end (an acetyl group and an amide) that also make the chain harder for enzymes to chew up.
If one-letter amino acid codes are new to you, our amino acid codes chart explains them.
How does P21 work? The research explained
Researchers have proposed a few linked mechanisms, based mainly on mouse work. A 2016 review from the team that developed it summarises them (Kazim and Iqbal, Molecular Neurodegeneration, 2016):
Raising BDNF levels
In animals given P21, it has been linked with higher levels of BDNF in the brain. BDNF is one of the best-studied proteins in memory research because it supports synapses, the connection points between neurons.
Encouraging new neurons in the hippocampus
The hippocampus is a brain region involved in learning and memory, and it is one of the few places where new neurons keep forming in adult mammals. Several studies reported more new and maturing neurons in the dentate gyrus, part of the hippocampus, in animals given P21. The authors connect this partly to reduced signalling through a pathway called LIF (leukaemia inhibitory factor).
Calming the enzyme GSK-3β
GSK-3β is an enzyme that adds phosphate groups to tau, a protein that clumps abnormally in Alzheimer’s disease. The P21 studies report that higher BDNF went along with lower GSK-3β activity, and less abnormal tau in mouse models.
These mechanisms come from animal experiments and are a working model, not settled science.
What have studies on P21 found so far?
Most of the published research falls into three groups.
Memory and learning in normal and older animals
The first paper reported that P21 improved learning and short-term and spatial memory in normal adult mice, alongside more new neurons in the hippocampus (2010). A later study in ageing rats reported less age-related decline in memory tasks and better markers of neurogenesis and synaptic health (Bolognin et al., Neurobiology of Aging, 2014).
Alzheimer’s disease mouse models
Much of the work uses 3xTg-AD mice, which are bred to develop amyloid plaques and tau tangles. Over a 12-month study, P21 was linked with less abnormal tau, lower soluble amyloid-beta, and improved memory, neurogenesis and synaptic markers (Kazim et al., Neurobiology of Disease, 2014). Follow-up studies looked at starting earlier in life and reported fewer synaptic and memory problems later on (Wei et al., 2020).
Down syndrome and CDKL5 models
In a mouse model of Down syndrome, early exposure to P21 was linked with less developmental delay and better adult memory (Kazim et al., Scientific Reports, 2017). Not every result has been positive, though. A 2024 study in a model of CDKL5 deficiency disorder found clear benefits in cells, but in mice P21 did not raise BDNF or fix brain structure changes, and behavioural benefit was limited (Mottolese et al., 2024).
P21 vs other nootropic research peptides
P21 is often mentioned alongside other peptides studied in brain research, but they work in different ways:
- P21: a CNTF-derived fragment linked with BDNF and new-neuron formation in rodent studies.
- Dihexa: an angiotensin IV-based compound studied for its effects on the HGF/c-Met pathway. See our Dihexa research guide.
- Semax and Selank: short peptides with a long history of Russian research. See our Semax research guide.
Adamax borrows P21’s adamantane modification and adds it to the Semax sequence. Our guide Adamax vs Semax explains what that change is meant to do and what is still unproven.
What are the limits of the P21 evidence?
It is worth being honest about the gaps:
- No human data. We found no human trial results in PubMed and no registered trials on ClinicalTrials.gov.
- Mostly one research group. Nearly all P21 papers come from the laboratory that designed it. Independent replication is limited.
- Possible conflicts of interest. The lead scientist has disclosed patents on P21 and a company developing it, as noted in the 2024 paper.
- Animal models are not people. Mouse models of Alzheimer’s disease copy some features of the condition, not all of them.
A study about P21 as a molecule also says nothing about whether a particular vial sold online is the right compound at the stated purity. That is where batch testing comes in.
Buying P21 for laboratory research in the UK
If your lab is sourcing P21, a few simple checks help:
- Ask for a batch-matched Certificate of Analysis (COA). Because P21 carries an unusual adamantane group, a mass spectrometry identity check matters as much as the HPLC purity figure. Our guide on how to read a COA explains what to look for.
- Plan storage. Freeze-dried peptides keep best cold, dry and away from light. See our peptide storage guide.
- Compare suppliers on evidence. Our page on the best research peptides in the UK sets out what a trustworthy supplier should show you.
Peptides UK lists P21 for lab research in a 10mg vial, HPLC and COA Verified, with the COA available on request by emailing [email protected]. You can browse the rest of the range in our research peptide shop.
Is P21 legal in the UK?
P21 has no UK marketing authorisation, so it is not a medicine. Research peptides like it are supplied in the UK for laboratory research use only. Whether a product counts as a medicine depends on how it is presented and used, so labs should follow current guidance from the MHRA and their own institutional rules. This article is not legal advice.
Frequently asked questions
What is P21 peptide?
P21, also written P021 or Peptide 021, is a small synthetic peptide designed from the most active region of ciliary neurotrophic factor (CNTF), a natural protein that supports nerve cells. In mouse studies it has been linked with more new neurons in the hippocampus and better scores on memory tasks.
Is P21 the same as P021?
Yes, in the research literature they refer to the same compound. The first 2010 paper called it P21, and later papers from the same New York laboratory mostly use P021 or Peptide 021. It is not the same thing as p21 (CDKN1A), a protein inside cells that helps control cell division.
What is the P21 peptide sequence?
Published papers describe P021 as Ac-DGGL(A)G-NH2. The core is four amino acids, D-G-G-L, taken from CNTF. An adamantane-modified glycine is added at one end to help it resist breakdown and cross the blood-brain barrier in animal studies, and both ends are capped (acetyl at the start, amide at the end).
Has P21 been tested in humans?
We found no published human trial results for P21 in PubMed, and no registered trials for it on ClinicalTrials.gov when this guide was written. All of the published evidence comes from cell models, mice and rats.
Is P21 legal in the UK?
P21 is not a licensed medicine in the UK. Like other research peptides, it is supplied for laboratory research use only. Whether a product counts as a medicine depends on how it is presented and used, so labs should follow current MHRA guidance and their own institutional rules. This is not legal advice.
All Peptides UK products are for laboratory research use only. They are not medicines and are not for human or veterinary use. This article is for educational purposes and is not medical or legal advice.